Health News Archive - May 10, 2010
SCHAUMBURG, Ill., May 10 /PRNewswire-USNewswire/ -- When it comes to tanning, dermatologists have long suspected that most people need an attitude adjustment.
NAGOYA, Japan, May 10 /PRNewswire/ -- Menicon Co., Ltd. announced on May 10 the appointment of Jackson Leung as North Asia Business Development Director in Menicon's Global Strategy & Operations group with immediate effect.
TOKYO, May 10, 2010 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) announce the commencement of the Phase III clinical programme by Novartis, with QVA149, a once-daily, dry powder bronchodilator for inhalation combining a fixed dose of the once-daily beta2-agonist QAB149 (indacaterol) and the long-acting muscarinic antagonist NVA237 (glycopyrronium bromide) for the treatment of chronic obstructive pulmonary disease (COPD).
SINGAPORE, May 10 /PRNewswire/ -- Corporate companies bear approximately 25% of the total nation's health expenditures in the USA.
KINGWOOD, Texas, May 10 /PRNewswire-FirstCall/ -- International Merchant Advisors, Inc. (Pink Sheets: IMAI) www.imaiinc.com announced today that the company's client, Healing Arts Cooperative Medical Marijuana is opening a new location in San Diego.
NEW YORK, May 10 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc.
NANJING, China, May 10 /PRNewswire-Asia-FirstCall/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2010 on Tuesday, May 18, 2010, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m.
THE WOODLANDS, Texas, May 10 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc.
LOS ALTOS, Calif., May 10 /PRNewswire/ -- InteKrin Therapeutics Inc. announced today that Linda Slanec Higgins, PhD has been named President and Chief Executive Officer.
EATONTOWN, N.J., May 10 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the first quarter ended March 31, 2010.